Citigroup »

Pyxis Oncology shares owned by Citigroup

Quarter-by-quarter ownership of Pyxis Oncology (PYXS) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Pyxis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Pyxis Oncology held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pyxis Oncology by Citigroup

Quarter filed Position value Share count Share price at filing
2024-03-31 $190k 45k 4.26
2022-12-31 $479k 358k 1.34
2022-09-30 $615k 312k 1.97
2021-12-31 $35k 3.2k 10.92

More positions owned by Citigroup

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Tesla Motors (TSLA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)

View all positions for Citigroup

Top funds holding Pyxis Oncology

Deep Track Capital
Laurion Capital Management
Balyasny Asset Management
Ikarian Capital
Vanguard Group
Standard Life Aberdeen
Millennium Management
Superstring Capital Management
Boothbay Fund Management
Monashee Investment Management
Hillhouse Capital Advisors
Geode Capital Management
Goldman Sachs Group
Decheng Capital
BlackRock

View all funds holding Pyxis Oncology